Managing Severe Hypoxic Respiratory Failure in COVID-19

Area of Science:

• Critical Care Medicine
• Pulmonology
• Infectious Diseases

Background:

• Severe COVID-19 infection frequently leads to adult respiratory distress syndrome (ARDS), a critical condition characterized by severe hypoxic respiratory failure.
• The management of ARDS in the context of the COVID-19 pandemic has necessitated the evolution of respiratory support strategies.

Purpose of the Study:

• To review current strategies for improving oxygenation in patients with severe COVID-19 and ARDS.
• To discuss the role of mechanical ventilation, prone positioning, and other therapies in managing ARDS.

Main Methods:

• Review of recent literature on ARDS management in COVID-19 patients.
• Analysis of evidence for non-invasive support, invasive mechanical ventilation, and adjunctive therapies.
• Evaluation of the effectiveness of prone positioning and inhaled pulmonary vasodilators.

Main Results:

• Lung protective ventilation, including low tidal volumes and appropriate positive end-expiratory pressure, is crucial for intubated patients.
• Intermittent prone positioning improves survival and can be safely applied to spontaneously breathing patients, potentially reducing the need for intubation.
• Inhaled pulmonary vasodilators have not demonstrated improved survival or cost-effectiveness in COVID-19 ARDS and should be used judiciously.

Conclusions:

• Optimal management of severe ARDS in COVID-19 requires a multi-faceted approach including lung protective ventilation and prone positioning.
• Experienced centers with established ARDS management protocols and escalation of care plans are associated with better patient outcomes.
• Careful consideration of adjunctive therapies, such as inhaled pulmonary vasodilators, is necessary based on current evidence.